ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.
ETFOptimize | HOME
Close Window
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DNAnexus and Oracle Collaborate to Advance Precision Health

By: via Business Wire

DNAnexus, Inc., the provider of the Precision Health Data Cloud, today announced that it will collaborate with Oracle to advance precision health.

This visionary endeavor is intended to drive scientific breakthroughs and improve patient outcomes globally by accelerating innovation in genomics and healthcare. This collaboration will:

  • Focus on connecting Oracle’s and DNAnexus’ respective ecosystems. This includes making the DNAnexus platform seamlessly available to global Oracle Cloud Infrastructure, Oracle Health, and Oracle Database customers. In addition, customers will be able to use OCI integration services for their healthcare applications.
  • Leverage Oracle’s expertise in accelerating AI pipelines and its industry partnerships to bring global customers even faster genomic analysis and better AI models. DNAnexus is already using OCI AI infrastructure to run genomic reports.

“Oracle’s focus on the simultaneous rapid global deployment of its cloud and electronic health records aligns very well with our industry-leading platform, which allows scientific innovators and healthcare professionals to manage, analyze, and collaborate on multi-omic, clinical, and real-world data,” said Thomas Laur, CEO at DNAnexus. “This connected ecosystem will enable users to reimagine the future of health, accelerate scientific discovery, and improve patient care.”

“Through our collaboration with DNAnexus, we believe we can help improve patient outcomes by connecting and delivering leading platforms for our customers,” said Dan Spellman, Global AI Cloud Director, Oracle. “Oracle’s vast ecosystem of partners and global footprint of 69 cloud regions is helping organizations accelerate innovations in healthcare and life sciences. Paired with DNAnexus’ expertise in genomic data management and analysis, we’re ultimately unlocking new insights and driving advancements in personalized medicine and healthcare.”

For more information, please stop by the Oracle (# 410) or the DNAnexus (# 28) booths at the Bio-IT World Conference & Expo, taking place April 15-17th in Boston.

About DNAnexus

DNAnexus enables biomedical organizations to accelerate scientific discovery and improve patient care with the Precision Health Data Cloud. The company provides scientific innovators and healthcare professionals with the ability to manage, analyze, and collaborate on multi-omic, clinical, and real-world data to unlock insights. DNAnexus actively manages more than 105 petabytes of data on behalf of a growing network of collaborations with leading pharmaceutical, clinical diagnostic, academic research, biobank, and government organizations. Today, more than 45,000 users across 48 countries and over 130 enterprise customers are harnessing the full potential of their data with the scalable and secure Precision Health Data Cloud. DNAnexus is headquartered in Mountain View, Calif. For more information, visit www.dnanexus.com or follow @DNAnexus.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.22
+21.36 (9.58%)
AAPL  270.37
-1.03 (-0.38%)
AMD  256.12
+1.28 (0.50%)
BAC  53.45
+0.42 (0.79%)
GOOG  281.82
-0.08 (-0.03%)
META  648.35
-18.12 (-2.72%)
MSFT  517.81
-7.95 (-1.51%)
NVDA  202.49
-0.40 (-0.20%)
ORCL  262.61
+5.72 (2.23%)
TSLA  456.56
+16.46 (3.74%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.


 
IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.